A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.

Clinical trial NCT03106987 · COMPLETED

Trial details

NCT number: NCT03106987
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2017-06-08
Primary completion: 2021-02-15
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.